These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15935811)

  • 1. Quinone oxidoreductases in protection against myelogenous hyperplasia and benzene toxicity.
    Iskander K; Jaiswal AK
    Chem Biol Interact; 2005 May; 153-154():147-57. PubMed ID: 15935811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene in mice causes myelogenous hyperplasia.
    Long DJ; Gaikwad A; Multani A; Pathak S; Montgomery CA; Gonzalez FJ; Jaiswal AK
    Cancer Res; 2002 Jun; 62(11):3030-6. PubMed ID: 12036909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity.
    Long DJ; Iskander K; Gaikwad A; Arin M; Roop DR; Knox R; Barrios R; Jaiswal AK
    J Biol Chem; 2002 Nov; 277(48):46131-9. PubMed ID: 12351651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of the quinone oxidoreductases NQO1 and NQO2 strongly elevates the incidence and multiplicity of chemically induced skin tumors.
    Shen J; Barrios RJ; Jaiswal AK
    Cancer Res; 2010 Feb; 70(3):1006-14. PubMed ID: 20103645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NQO1 and NQO2 regulation of humoral immunity and autoimmunity.
    Iskander K; Li J; Han S; Zheng B; Jaiswal AK
    J Biol Chem; 2006 Oct; 281(41):30917-24. PubMed ID: 16905546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functions and distribution of NQO1 in human bone marrow: potential clues to benzene toxicity.
    Ross D
    Chem Biol Interact; 2005 May; 153-154():137-46. PubMed ID: 15935810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic susceptibility to benzene-induced toxicity: role of NADPH: quinone oxidoreductase-1.
    Bauer AK; Faiola B; Abernethy DJ; Marchan R; Pluta LJ; Wong VA; Roberts K; Jaiswal AK; Gonzalez FJ; Butterworth BE; Borghoff S; Parkinson H; Everitt J; Recio L
    Cancer Res; 2003 Mar; 63(5):929-35. PubMed ID: 12615705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6.
    Jaiswal AK; Burnett P; Adesnik M; McBride OW
    Biochemistry; 1990 Feb; 29(7):1899-906. PubMed ID: 1691923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NRH:quinone oxidoreductase2 (NQO2).
    Long DJ; Jaiswal AK
    Chem Biol Interact; 2000 Dec; 129(1-2):99-112. PubMed ID: 11154737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BALT development and augmentation of hyperoxic lung injury in mice deficient in NQO1 and NQO2.
    Das A; Kole L; Wang L; Barrios R; Moorthy B; Jaiswal AK
    Free Radic Biol Med; 2006 May; 40(10):1843-56. PubMed ID: 16678022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
    Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
    Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity.
    Moran JL; Siegel D; Ross D
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8150-5. PubMed ID: 10393963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NRH:quinone oxidoreductase 2 (NQO2) protein competes with the 20 S proteasome to stabilize transcription factor CCAAT enhancer-binding protein α (C/EBPα), leading to protection against γ radiation-induced myeloproliferative disease.
    Xu J; Patrick BA; Jaiswal AK
    J Biol Chem; 2013 Nov; 288(48):34799-808. PubMed ID: 24142791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of the antioxidant enzymes NAD(P)H: Quinone oxidoreductase 1 (NQO1) and NRH: Quinone oxidoreductase 2 (NQO2) with pharmacological agents, endogenous biochemicals and environmental contaminants.
    Rashid MH; Babu D; Siraki AG
    Chem Biol Interact; 2021 Aug; 345():109574. PubMed ID: 34228969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for NQO1 and NQO2 catalyzed reduction of ortho- and para-quinone methides.
    Kucera HR; Livingstone M; Moscoso CG; Gaikwad NW
    Free Radic Res; 2013 Dec; 47(12):1016-26. PubMed ID: 24074361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations.
    den Braver-Sewradj SP; den Braver MW; Toorneman RM; van Leeuwen S; Zhang Y; Dekker SJ; Vermeulen NPE; Commandeur JNM; Vos JC
    Chem Res Toxicol; 2018 Feb; 31(2):116-126. PubMed ID: 29281794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review.
    Nebert DW; Roe AL; Vandale SE; Bingham E; Oakley GG
    Genet Med; 2002; 4(2):62-70. PubMed ID: 11882782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No associations between Parkinson's disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes.
    Okada S; Farin FM; Stapleton P; Viernes H; Quigley SD; Powers KM; Smith-Weller T; Franklin GM; Longstreth WT; Swanson PD; Checkoway H
    Neurosci Lett; 2005 Mar; 375(3):178-80. PubMed ID: 15694256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants in metabolizing genes NQO1, NQO2, MTHFR and risk of prostate cancer: a study from North India.
    Mandal RK; Nissar K; Mittal RD
    Mol Biol Rep; 2012 Dec; 39(12):11145-52. PubMed ID: 23054000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NRH:quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20s proteasomal degradation leading to stabilization and activation of p53.
    Gong X; Kole L; Iskander K; Jaiswal AK
    Cancer Res; 2007 Jun; 67(11):5380-8. PubMed ID: 17545619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.